Navigation Links
Murrieta Genomics Welcomes Tx Genetic Research to Incubator
Date:7/9/2019

Murrieta Genomics, a launch pad for genomic sequencing startups, has accepted Tx Genetic Research into its incubator program. The founder and CEO of Tx Genetic, Helen Harrison, has spent several years researching and conducting studies looking to improve the lives of those suffering from epithelial connective tissue disorders.

“We are pleased and excited to join the growing health and biotech industry in SW Riverside County being nurtured by Murrieta Genomics,” stated Harrison. “We appreciate the ability of Murrieta Genomics and their team of advisory board members to help us launch our new company and bring new ideas and products to market.”

Tx Genetic Research provides genetic information and nutritional guidance to support the health of our “inside skin.” This “skin” or connective tissue that lines our tracts, vessels and organs allows them to maintain their form but also shift inside the body when we bend or twist. This is a necessary component to enable us to absorb nutrients we ingest but defend against pollution or germs that we swallow or breath.

Injuries, inflammation, toxins and genetic mutations can decrease the effectiveness of our inner connective tissue. Some of these mutations contribute to the development of certain conditions, such as leaky gut, interstitial cystitis and irritable bowel syndrome. Tx Genetic Research was founded on the goal of helping people treat their “inside skin” well for life.

“We were extremely impressed with the depth of research and knowledge that Helen displayed in our very first meeting,” said John Powers, President and COO of Murrieta Genomics. “She has an inner drive to help people live a pain free life and we believe that Tx Genetic Research will provide relief to millions.”

About Murrieta Genomics
Murrieta Genomics provides access to next generation sequencing technology for researchers in the health, veterinary, agriculture, forensics and direct to consumer industries. The company is a true business incubator, offering mentorship and guidance from both the scientific and business perspectives to aspiring genomic-related entrepreneurs. The founders of Murrieta Genomics have extensive background in business, finance, science and technology. They are supplemented with a prestigious advisory board from both business and science. In addition to low-cost incubation, the company provides hands-on consulting and will provide seed funding to qualified incubator graduates as well as connections to next-stage funders. For more information, visit http://www.murrietagenomics.com.

Read the full story at https://www.prweb.com/releases/murrieta_genomics_welcomes_tx_genetic_research_to_incubator/prweb16428644.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Murrieta Genomics To Sponsor SBIR/STTR Workshop - Entrepreneurs to Learn About “America’s Seed Fund”
2. Murrieta Genomics Welcomes Second Genomic Sequencing Incubator Company
3. Gateway Genomics SneakPeek Noninvasive Prenatal Test (NIPT) Identifies Gender with Cell-free Fetal DNA from Microvolumes of Self-collected Maternal Blood
4. Karius Announces the Clinical Investigator Award for Applied Pediatric Infectious Disease Genomics
5. Genomics Firm Nabsys Completes Financial Restructuring and Reinstates Technical Leadership Team
6. Newborn Screening Ontario Inks Deal with Tute Genomics, UNIConnect Team to Deliver Informatics Infrastructure for NGS Testing
7. Rubicon Genomics Announces Eurofins Scientific Will Distribute Its Suite of DNA Library Preparation Kits in U.S.
8. Den 10. internationale konference om Genomics (ICG-10) åbner i oktober
9. La 10e International Conference on Genomics (ICG-10) doit souvrir en octobre
10. La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre
11. The 10th International Conference on Genomics (ICG-10) to Open in October
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, has ... own adipose-derived stem cells to treat their osteoarthritis. The first clinical trial, expected to ... , This is the first of several planned clinical trials which will ...
(Date:7/21/2019)... ... July 20, 2019 , ... ... ( http://www.fluidimaging.com ) announced today the release of the biggest software update ... and characterization platform will provide a significant increase in productivity for its ...
(Date:7/19/2019)... (PRWEB) , ... July 19, 2019 , ... ... Solids between Amorphous and Crystalline States – Insights from Synchrotron X-ray Pair Distribution ... Improved Pharma, along with Chris Benmore of Argonne National Laboratory and Gabriel de ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... ... will add 80 of its scientific journals to DeepDyve’s rental service for peer-reviewed ... DeepDyve’s continually expanding library of more than 20 million articles, sourced from more ...
(Date:6/6/2019)... CYPRESS, Calif. (PRWEB) , ... June 05, 2019 , ... ... pharmaceutical, biotechnology and medical device industries, announced today that they will be receiving 3 ... in San Diego, CA. WCCT received 2 awards in the categories of overall Quality ...
(Date:5/31/2019)... ... May 30, 2019 , ... Object Pharma, ... the strategic acquisition of Metabiologics, Inc., a globally recognized leader in the production ... and commercialization rights to a full spectrum of botulinum neurotoxins, as well as ...
(Date:5/15/2019)... ... , ... Milton Hershey School® has named William Charles Ballough Harding ’78 the ... where he is changing lives by creating solutions to global healthcare challenges through the ... of our founders – Milton and Catherine Hershey – who always hoped for Milton ...
Breaking Biology Technology: